BioLife Solutions Inc (BLFS)

Operating profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands -70,823 -106,939 -89,896 -151,179 -145,541 -114,735 -114,154 -42,146 -35,160 -22,104 -12,191 -7,592 -6,241 -1,593 -1,119 -416 -220 1,584 3,551 4,089
Revenue (ttm) US$ in thousands 142,796 154,008 161,427 162,452 161,032 154,468 147,521 138,192 118,837 96,581 74,057 52,773 48,087 41,249 36,673 33,590 27,367 25,090 23,762 22,134
Operating profit margin -49.60% -69.44% -55.69% -93.06% -90.38% -74.28% -77.38% -30.50% -29.59% -22.89% -16.46% -14.39% -12.98% -3.86% -3.05% -1.24% -0.80% 6.31% 14.94% 18.47%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-70,823K ÷ $142,796K
= -49.60%

The operating profit margin of BioLife Solutions Inc has shown significant fluctuations over the past few quarters. In the most recent quarter ending Dec 31, 2023, the operating profit margin was at -49.60%, indicating that the company's operating expenses exceeded its operating income by a considerable margin. This is a deterioration from the previous quarter's operating profit margin of -69.44%.

Looking further back, the trend continues to show variability in the operating profit margin. In the same quarter of the previous year (Sep 30, 2022), the operating profit margin was at -74.28%, which was notably higher than the most recent quarter, but still in the negative territory.

The highest operating profit margin observed in the data provided was at 18.47% in the quarter ending Jun 30, 2019. Since then, there has been a general decline in the operating profit margin, with intermittent improvements and deteriorations.

Overall, the operating profit margin of BioLife Solutions Inc has been volatile, indicating fluctuations in the company's ability to generate profits from its core operations. This suggests that the company may be facing challenges in managing its operating expenses or generating sufficient revenue to cover these expenses.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating profit margin
BioLife Solutions Inc
BLFS
-49.60%
CONMED Corporation
CNMD
9.69%
LivaNova PLC
LIVN
-6.26%
Masimo Corporation
MASI
6.67%
Medtronic PLC
MDT
15.60%